Use of a gene expression signature to identify trimetazidine for repurposing to treat bipolar depression.
Bortolasci CC, Kidnapillai S, Spolding B, Truong TTT, Connor T, Swinton C, Panizzutti B, Liu ZSJ, Sanigorski A, Dean OM, Crowley T, Richardson M, Bozaoglu K, Vlahos K, Cowdery S, Watmuff B, Steyn SF, Wolmarans W, Engelbrecht BJ, Perry C, Drummond K, Pang T, Jamain S, Gray L, McGee SL, Harvey BH, Kim JH, Leboyer M, Berk M, Walder K.
Bortolasci CC, et al. Among authors: berk m.
Bipolar Disord. 2023 Dec;25(8):661-670. doi: 10.1111/bdi.13319. Epub 2023 Mar 23.
Bipolar Disord. 2023.
PMID: 36890661
Free PMC article.